{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:42:04Z","timestamp":1773117724623,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12519-018-0205-z","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T01:25:55Z","timestamp":1542331555000},"page":"148-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-term prognosis of low-risk neuroblastoma treated by surgery alone: an experience from a single institution of China"],"prefix":"10.1007","volume":"15","author":[{"given":"Wei","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui-Ran","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Min","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"key":"205_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/14737140.2017.1285230","volume":"17","author":"SB Whittle","year":"2017","unstructured":"Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017;17:369\u201386.","journal-title":"Expert Rev Anticancer Ther."},{"key":"205_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/08880018.2017.1330375","volume":"34","author":"AA Ahmed","year":"2017","unstructured":"Ahmed AA, Zhang L, Reddivalla N, Hetherington M. Neuroblastoma in children: update on clinicopathologic and genetic prognostic factors. Pediatr Hematol Oncol. 2017;34:165\u201385.","journal-title":"Pediatr Hematol Oncol."},{"key":"205_CR3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/pbc.24433","volume":"60","author":"JR Park","year":"2013","unstructured":"Park JR, Bagatell R, London WB, Maris JM, Cohn SL, Mattay KK, et al. Children\u2019s Oncology Group\u2019s 2013 blueprint for research: neuroblastoma. Pediatr Blood Cancer. 2013;60:985\u201393.","journal-title":"Pediatr Blood Cancer."},{"key":"205_CR4","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1200\/JCO.2011.37.9990","volume":"30","author":"DR Strother","year":"2012","unstructured":"Strother DR, London WB, Schmidt ML, Brodeur GM, Shimada H, Thorner P, et al. Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of children\u2019s oncology group study P9641. J Clin Oncol. 2012;30:1842\u20138.","journal-title":"J Clin Oncol."},{"key":"205_CR5","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1200\/JCO.2005.05.571","volume":"23","author":"WB London","year":"2005","unstructured":"London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, et al. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the children\u2019s oncology group. J Clin Oncol. 2005;23:6459\u201365.","journal-title":"J Clin Oncol."},{"key":"205_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/j.sempedsurg.2016.09.007","volume":"25","author":"EA Newman","year":"2016","unstructured":"Newman EA, Nuchtern JG. Recent biologic and genetic advances in neuroblastoma: implications for diagnostic, risk stratification, and treatment strategies. Semin Pediatr Surg. 2016;25:257\u201364.","journal-title":"Semin Pediatr Surg."},{"key":"205_CR7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1056\/NEJMoa1001527","volume":"363","author":"DL Baker","year":"2010","unstructured":"Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, et al. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med. 2010;363:1313\u201323.","journal-title":"N Engl J Med."},{"key":"205_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.semcancer.2011.07.002","volume":"21","author":"I \u00d8ra","year":"2011","unstructured":"\u00d8ra I, Eggert A. Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research. Semin Cancer Biol. 2011;21:217\u201328.","journal-title":"Semin Cancer Biol."},{"key":"205_CR9","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jama.2012.228","volume":"307","author":"NK Cheung","year":"2012","unstructured":"Cheung NK, Zhang J, Lu C, Parker M, Bahrami A, Tickoo SK, et al. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA. 2012;307:1062\u201371.","journal-title":"JAMA."},{"key":"205_CR10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1200\/JCO.2007.13.9493","volume":"26","author":"J Schneiderman","year":"2008","unstructured":"Schneiderman J, London WB, Brodeur GM, Castleberry RP, Look AT, Cohn SL. Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children\u2019s Oncology Group. J Clin Oncol. 2008;26:913\u20138.","journal-title":"J Clin Oncol."},{"key":"205_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/jnci\/89.5.373","volume":"89","author":"LC Bowman","year":"1997","unstructured":"Bowman LC, Castleberry RP, Cantor A, Joshi V, Cohn SL, Smith EI, et al. Genetic staging of unresectable or metastatic neuroblastomain infants: a pediatric oncology group study. J Natl Cancer Inst. 1997;89:373\u201380.","journal-title":"J Natl Cancer Inst."},{"key":"205_CR12","doi-asserted-by":"publisher","first-page":"8483","DOI":"10.1200\/JCO.2005.02.4661","volume":"23","author":"G Cecchetto","year":"2005","unstructured":"Cecchetto G, Mosseri V, De Bernardi B, Helardot P, Monclair T, Costa E, et al. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol. 2005;23:8483\u20139.","journal-title":"J Clin Oncol."},{"key":"205_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/SLA.0b013e31826cbbbd","volume":"256","author":"JG Nuchtern","year":"2012","unstructured":"Nuchtern JG, London WB, Barnewolt CE, Naranjo A, McGrady PW, Geiger JD, et al. A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children\u2019s Oncology Group study. Ann Surg. 2012;256:573\u201380.","journal-title":"Ann Surg."},{"key":"205_CR14","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1200\/JCO.1998.16.4.1265","volume":"16","author":"K Yamamoto","year":"1998","unstructured":"Yamamoto K, Hanada R, Kikuchi A, Ichikawa M, Aihara T, Oguma E, et al. Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol. 1998;16:1265\u20139.","journal-title":"J Clin Oncol."},{"key":"205_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jpedsurg.2004.10.062","volume":"40","author":"T Oue","year":"2005","unstructured":"Oue T, Inoue M, Yoneda A, Kubota A, Okuyama H, Kawahara H, et al. Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study. J Pediatr Surg. 2005;40:359\u201363.","journal-title":"J Pediatr Surg."},{"key":"205_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/08880018.2017.1373315","volume":"34","author":"D Coughlan","year":"2017","unstructured":"Coughlan D, Gianferante M, Lynch CF, Stevens JL, Harlan JL. Treatment and survival of childhood neuroblastoma: evidence from a population-based study in the United States. Pediatr Hematol Oncol. 2017;34:320\u201330.","journal-title":"Pediatr Hematol Oncol."},{"key":"205_CR17","first-page":"452","volume":"29","author":"KR Dong","year":"2009","unstructured":"Dong KR, Li K, Gao JC, Lv ZB, Xiao XM. Treatment results of neuroblastoma with a standardization protocol. Chin J Pedatr Surg. 2009;29:452\u20135.","journal-title":"Chin J Pedatr Surg."}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-018-0205-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-018-0205-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-018-0205-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T19:37:13Z","timestamp":1573846633000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-018-0205-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,16]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["205"],"URL":"https:\/\/doi.org\/10.1007\/s12519-018-0205-z","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,16]]},"assertion":[{"value":"9 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No financial or nonfinancial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}